The Novo Nordisk Foundation is an enterprise foundation with philanthropic objectives, established in Denmark in 1924. Our vision is to improve people’s health and contribute to the sustainability of society and the planet. Through strategic grant giving, partnerships, and long-term investments, the Foundation seeks to generate impact that benefits both current and future generations. Community guidelines We welcome dialogue on our channels and value respectful engagement. However, we reserve the right to remove comments that are offensive, racist, sexist, discriminatory, spam, or otherwise inappropriate. Repeated violations may result in being blocked from our channels.
解锁市场时间线与信号动态
最近 90 天内有 162 个信号。
该公司进入各个市场的顺序 — 从最早到最新
注册以查看完整信号动态
Novo Nordisk Foundation 的国际扩张与竞争对手的对比情况
Novo Nordisk Foundation你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Novo Nordisk Foundation你 | 4 | 0 | -72% | 162 | 11 |
Senior Digital Workplace Manager (Maternity Cover)
查看职位Gentofte, Capital Region of Denmark, Denmark · 上周
Kontorelever
查看职位Gentofte, Capital Region of Denmark, Denmark · 3周前
Student Assistant, Public Affairs
查看职位Gentofte, Capital Region of Denmark, Denmark · 3周前
We’re launching a new roadmap to help unlock the potential of regenerative medicine in Europe. Based on a major analysis, it sets out what it will take to move from strong science to real-world therapies that treat or even cure disease.Today, Europe has the scientific foundations to lead globally. But too often, new knowledge isn’t translated into startups, clinical programmes, and approved treatments.We commissioned an analysis of Europe’s regenerative medicine landscape to better understand wh ...
已结束
Novo Nordisk Foundation and Global Health EDCTP3 launch partnership to advance global health research - Novo Nordisk Fonden
已结束
From foundational mRNA breakthroughs to unlocking the genetic mysteries of rare diseases, recipients of the Novo Nordisk Foundation Prize for Biomedicine don’t just study human health - they revolutionize it.This prestigious award honors outstanding scientists whose pioneering research has led to major medical breakthroughs and life-saving clinical applications.If you know a visionary scientist whose work is fundamentally shifting the paradigm of biomedicine, their contributions deserve the glob ...
已结束INTREPID联盟报告指出,14个高风险病毒家族中仅6个有8种病毒疾病进入临床试验,3个家族完全没有抗病毒药物开发,凸显大流行准备的关键缺口。
诺和诺德基金会推出CardioMetabolic Bridge,一项泛欧洲倡议,通过资金和指导支持学术研究,加速心脏代谢疾病的药物发现和治疗开发。
由Lene B. Oddershede领导的诺和诺德基金会正投资于量子计算，用于医疗保健和药物发现，长期视角约为10年。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Novo Nordisk Foundation 的业务、市场和增长信号的快速解答。
